Home › Funds › MANNING & NAPIER ADVISORS LLC › ELV

MANNING & NAPIER ADVISORS LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

MANNING & NAPIER ADVISORS LLC reported holding 333,472 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$140.7M, representing 1.90% of its reported portfolio and ranking #13 among its reported holdings. MANNING & NAPIER ADVISORS LLC has disclosed ELV holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)333.47K sh
Reported value held$140.73M
Portfolio Weight1.90%
First reportedQ3 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How MANNING & NAPIER ADVISORS LLC's ELV position evolved

MANNING & NAPIER ADVISORS LLC first disclosed a stake in ELV in Q3 2025 at 24,189 shares (US$7.8M). The position peaked in Q2 2026 at 367,297 shares, worth US$142.5M. Across 5 filings, MANNING & NAPIER ADVISORS LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 333,472 shares valued at US$140.7M — a reduction of -33,825 shares quarter over quarter.. Notable position changes include a 1423% increase in Q4 2025 (shares fell 16% over the following quarter), a 29% increase in Q1 2026 (shares rose 33% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 24.19K $7.82M New
Q4 2025 368.43K $129.15M Add
Q1 2026 475.20K $139.12M Add
Q2 2026 367.30K $142.52M Reduce
Q3 2026 333.47K $140.73M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has MANNING & NAPIER ADVISORS LLC held ELV?

MANNING & NAPIER ADVISORS LLC has disclosed ELV holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is MANNING & NAPIER ADVISORS LLC's current position in ELV?

As of Q3 2026, MANNING & NAPIER ADVISORS LLC holds 333.47K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $140.73M, representing 1.90% of its reported portfolio and ranking #13.

Has MANNING & NAPIER ADVISORS LLC been buying or selling ELV?

In the latest 13F filing (Q3 2026), MANNING & NAPIER ADVISORS LLC reduced its position in ELV. The position peaked in Q2 2026 at 367.30K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.